Trump calls Colombian president 'a drug leader', vows end to payments

Read a summary of this article on FAST.
Get bite-sized news via a new
cards interface. Give it a try.
Click here to return to FAST Tap here to return to FAST
FAST

US President Donald Trump called Colombian President Gustavo Petro an "illegal drug leader" on Sunday (Oct 19) and said the United States would cease "large-scale payments and subsidies" to the South American nation.

"The purpose of this drug production is the sale of massive amounts of product into the United States, causing death, destruction, and havoc," he said in a Truth Social post. 

The Colombian embassy in Washington, DC, did not immediately respond to a request for comment. Relations between Bogota and Washington have frayed since Trump returned to office.

Last month, the United States revoked Petro's visa after he joined a pro-Palestinian demonstration in New York and urged US soldiers to disobey Trump's orders.

Last year, Petro pledged to tame coca-growing regions in Colombia with massive social and military intervention, but the strategy has brought little success.

In September, Trump designated countries such as Afghanistan, Bolivia, Myanmar, Colombia and Venezuela among those the United States believes to have "failed demonstrably" in upholding counternarcotics agreements during the past year.

He blamed Colombia's political leadership for the failure to meet its drug control obligations.

"Petro ... is an illegal drug leader strongly encouraging the massive production of drugs," said Trump, saying US payments and subsidies to Colombia were a rip-off.

"AS OF TODAY, THESE PAYMENTS, OR ANY OTHER FORM OF PAYMENT, OR SUBSIDIES, WILL NO LONGER BE MADE," he wrote in capital letters. It was not clear what Trump was referring to.

Sign up for our newsletters

Get our pick of top stories and thought-provoking articles in your inbox

Subscribe here

Get the CNA app

Stay updated with notifications for breaking news and our best stories

Download here

Get WhatsApp alerts

Join our channel for the top reads for the day on your preferred chat app

Join here